Clinical characteristics of subjects
Subject . | CDC disease stage* . | CD4 count (cells/mm3) . | Plasma viremia (copies/mL) . |
---|---|---|---|
136 | B2 | 410 | 4338 |
163 | A2 | 450 | < 500 |
215 | B3 | 150 | 46 322 |
216 | C3 | 50 | 5975 |
219 | A2 | 370 | 1512 |
237 | C2 | 260 | 3430 |
307 | B2 | 283 | 8633 |
348 | A1 | 680 | < 500 |
350 | A1 | 1005 | 70 |
351 | A1 | 571 | < 500 |
606 | A2 | 615 | < 50 |
701 | B3 | 71 | < 50 |
703 | A1 | 529 | < 50 |
704 | A1 | Unknown | < 50 |
705 | A2 | 650 | < 50 |
Subject . | CDC disease stage* . | CD4 count (cells/mm3) . | Plasma viremia (copies/mL) . |
---|---|---|---|
136 | B2 | 410 | 4338 |
163 | A2 | 450 | < 500 |
215 | B3 | 150 | 46 322 |
216 | C3 | 50 | 5975 |
219 | A2 | 370 | 1512 |
237 | C2 | 260 | 3430 |
307 | B2 | 283 | 8633 |
348 | A1 | 680 | < 500 |
350 | A1 | 1005 | 70 |
351 | A1 | 571 | < 500 |
606 | A2 | 615 | < 50 |
701 | B3 | 71 | < 50 |
703 | A1 | 529 | < 50 |
704 | A1 | Unknown | < 50 |
705 | A2 | 650 | < 50 |
Defined by the lowest documented CD4 count.